ARCHIVES

Roche Markets CMV Test in Europe

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Concept Approved For New Quality Assurance Center

May 14, 1982

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

Procedures For Ending IGs Announced

July 10, 1992